Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
-5.79M
-
Total reported value, excl. options
-
$1.93B
-
Value change
-
-$76.7M
-
Put/Call ratio
-
0.85
-
Number of buys
-
65
-
Number of sells
-
-64
-
Price
-
$15.33
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2014
173 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q2 2014.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
of 162M outstanding shares and own 77.94% of the company stock.
Largest 10 shareholders include FMR LLC (19.8M shares), WELLINGTON MANAGEMENT CO LLP (16.7M shares), BVF INC/IL (9.21M shares), ORBIMED ADVISORS LLC (8.94M shares), MORGAN STANLEY (8.08M shares), VANGUARD GROUP INC (7.2M shares), JANUS CAPITAL MANAGEMENT LLC (6.28M shares), STATE OF WISCONSIN INVESTMENT BOARD (4.76M shares), BlackRock Fund Advisors (4.72M shares), and DEUTSCHE BANK AG\ (3.9M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.